Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) has 10 years of Tax Rate data on file, last reported at 0.54% in Q1 2026.

• On a quarterly basis, Tax Rate rose 12.0% year-over-year to 0.54% in Q1 2026; TTM through Mar 2026 was 0.62%, a 15.0% decrease from a year earlier, with the FY2025 full-year figure at 0.71%, down 35.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.54%, up from 0.71% in the prior quarter.
• Over the last five years, Tax Rate for RARE reached as high as 3.04% in Q4 2023 and fell as low as 2.63% in Q3 2022.
• Historically, Tax Rate has averaged 0.36% across 5 years, with a median of 0.41% in 2023.
• Across the five-year window, Tax Rate surged 317 bps in 2023 and slumped 334 bps in 2024, its largest moves.
• Year by year, Tax Rate stood at 0.12% in 2022, then soared by 2568 bps to 3.04% in 2023, then slumped by 110 bps to 0.3% in 2024, then slumped by 140 bps to 0.71% in 2025, then grew by 24 bps to 0.54% in 2026.
• Per Business Quant data, the three most recent Tax Rate figures were 0.54% in Q1 2026, 0.71% in Q4 2025, and 0.49% in Q3 2025.